advertisement
Zhang Y 105
Showing records 1 to 25 | Display all abstracts from Zhang Y104477 Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Tian F
Neuron 2022; 110: 2607-2624.e8
104762 Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
Zhang Y
Pharmaceutics 2022; 14:
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Zhang Y
Acta Ophthalmologica 2023; 101: e50-e60
105019 Non-invasive intracranial pressure estimation using ultrasonographic measurement of area of optic nerve subarachnoid space
Zhang Y
British Journal of Ophthalmology 2023; 107: 1716-1721
104977 A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Zhang Y
Eye Contact Lens 2022; 48: 439-444
104700 Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Secondary Glaucoma in Patients With Cytomegalovirus-Induced Corneal Endotheliitis
Wu W
Frontiers in microbiology 2022; 13: 940818
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Yang Y
Frontiers in cell and developmental biology 2022; 10: 925835
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)
Gao X
BMJ open 2022; 12: e062441
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Yang Z
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104792 Mechanisms of Qing-Gan Li-Shui Formulation in Ameliorating Primary Open Angle Glaucoma: An Analysis Based on Network Pharmacology
Mu L
Evidence-based Complementary and Alternative Medicine 2022; 2022: 8336131
105080 Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration
Zhang Y
Frontiers in cellular and infection microbiology 2022; 12: 968992
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Wu J
Frontiers in cell and developmental biology 2022; 10: 925835
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu J
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104792 Mechanisms of Qing-Gan Li-Shui Formulation in Ameliorating Primary Open Angle Glaucoma: An Analysis Based on Network Pharmacology
Dong Z
Evidence-based Complementary and Alternative Medicine 2022; 2022: 8336131
105019 Non-invasive intracranial pressure estimation using ultrasonographic measurement of area of optic nerve subarachnoid space
Cao K
British Journal of Ophthalmology 2023; 107: 1716-1721
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Hao J
Acta Ophthalmologica 2023; 101: e50-e60
104700 Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Secondary Glaucoma in Patients With Cytomegalovirus-Induced Corneal Endotheliitis
Jiang H
Frontiers in microbiology 2022; 13: 940818
105080 Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration
Zhou X
Frontiers in cellular and infection microbiology 2022; 12: 968992
104977 A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Wei Y
Eye Contact Lens 2022; 48: 439-444
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)
Lv A
BMJ open 2022; 12: e062441
104762 Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
Zhang C
Pharmaceutics 2022; 14:
104477 Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Cheng Y
Neuron 2022; 110: 2607-2624.e8
104977 A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Karunaratne IK
Eye Contact Lens 2022; 48: 439-444
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Lu W
Frontiers in cell and developmental biology 2022; 10: 925835
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu K
Journal of Medicinal Chemistry 2022; 65: 11745-11758